ArticleJournal of the American Chemical Society2025
Colloidal Crystals Engineered with DNA from Supramolecular Programmable Atom Equivalents with Stimuli-Responsive Cores.
Article in Journal of the American Chemical Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Oligonucleotide-functionalized nanoparticles (NPs), known as "programmable atom equivalents" (PAEs), are the primary building blocks for the field of colloidal crystal engineering with DNA. With these constructs, one typically uses canonical DNA-DNA interactions to control the colloidal crystallization process. Herein, DNA-modified perylene diimides that can assemble into spherical micellar PAEs are synthesized and characterized. These PAEs are held together via noncovalent interactions, and therefore both chemical and physical stimuli can be used to disassemble them and, consequently, modulate the structures of colloidal crystals made from them. When combined with gold nanoparticle PAEs of approximately the same size but with complementary DNA, these micellar PAEs assemble into BCC colloidal crystal lattices. Electron microscopy, UV-vis spectroscopy, and synchrotron small-angle X-ray scattering studies confirm the structural assignment. Spectroscopic and microscopy studies show that anionic aromatic molecules (1,3,6,8-pyrenetetrasulfonate) are capable of disrupting the supramolecular PAEs, which leads to disassembly of the colloidal crystal lattice. Molecular dynamics simulations and first-principles calculations provide further insight into the PAE core assembly process and notably suggest that it is independent of DNA valency and sequence. This work is important because it introduces a new strategy and extralattice chemical parameter for controlling colloidal crystals engineered with DNA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.